Health Care
Price
$86.43
+2.26%Market Cap
$9.85B
Day High
$86.50
Day Low
$84.74
Henry Schein (HSIC) delivered 6.3% revenue growth to $3.37B in Q1 2026, but net income declined 2.7% to $107M as SG&A expenses surged 9.6% and operating cash flow turned sharply negative at -$97M.
Key risk: Negative Operating Cash Flow
Henry Schein generated -$97M in operating cash flow in Q1 2026, a dramatic reversal from +$37M in Q1 2025. This cash burn, if sustained, could strain liquidity and limit the company's ability to fund operations, investments, or shareholder returns without additional borrowing.
Other Health Care Distributors companies